NT-ProBNP antibody

Catalog No. ABIN7849775

The Mouse Monoclonal anti-NT-ProBNP antibody (Clone C7) (ABIN7849775) specifically detects NT-ProBNP in WB, ELISA, LF and CLIA. The antibody is reactive with Human samples.

Quick Overview for NT-ProBNP antibody (ABIN7849775)

Target: NT-ProBNP (Pro-Brain Natriuretic Peptide (NT-ProBNP) (NT-ProBNP))

Reactivity: Human

Host: Mouse

Clonality: Monoclonal

Conjugate: This NT-ProBNP antibody is un-conjugated

Application: Western Blotting (WB), ELISA, Lateral Flow (LF), Chemiluminescence Immunoassay (CLIA)

Clone: C7

Product Details anti-NT-ProBNP Antibody

Purpose: Monoclonal Anti-NT-proBNP (Detection Ab)

Specificity: It specifically recognize the human NT-proBNP, and does not cross react with BNP and cardiac Troponin I.

Characteristics: This antibody may be used as in antibody pair experiments such as ELISA.

Purification: Protein A or G purified

Purity: >95 % by HPLC & SDS-PAGE

Immunogen: Recombinant human NT-proBNP.

Isotype: IgG1

Application Details

Application Notes: Optimal working dilution should be determined by the investigator.

Restrictions: For Research Use only

Handling

Format: Liquid

Buffer: 0.01 M PBS ( pH 7.4) without preservative.

Preservative: Without preservative

Handling Advice: Avoid repeated freeze and thaw cycles.

Storage: -20 °C

Storage Comment: Aliquot and store at -20°C for long term (at least one year). Avoid repeated freeze and thaw cycles.

Expiry Date: 12 months

Target Details for NT-ProBNP

Target: NT-ProBNP (Pro-Brain Natriuretic Peptide (NT-ProBNP) (NT-ProBNP))

Alternative Name: NT-proBNP

Background: The N-terminal prohormone of brain natriuretic peptide (NT-proBNP) is a 76 amino acid N-terminal fragment of brain natriuretic peptide.Both BNP and NT-proBNP levels in the blood are used for screening, diagnosis of acute congestive heart failure (CHF) and may be useful to establish prognosis in heart failure, as both markers are typically higher in patients with worse outcome.BNP may be a useful screening tool for left ventricular dysfunction in patients with history suggestive of heart disease and be usedto assist in forming a pretest probability, which in turn could greatly assist in appropriateness of patient referral and in optimization of drug therapy.